News & Spotlights, NNE-CTR, Larner College of Medicine, UVM

News Bits ...

Call for Proposals: 2024 Health Equity Summit

Discover and share exciting initiatives at the third annual Health Equity Summit, Building Solidarity: Sustainable Pathways Towards Health Equity. The Summit is a collaboration between community members, healthcare providers and educators to dismantle institutional barriers to health and enhance patient experiences.

Details

Dates: Monday, October 7, 4 - 6 pm: Poster presentations and kickoff reception

Tuesday, October 8, 8 am - 5 pm: Workshops and sessions

Location: Double Tree Hotel, 870 Williston Road, South Burlington, VT 05403 (Google Maps)

Sponsors: The 3rd Annual Health Equity Summit is a joint effort presented by the University of Vermont Health Network, the Larner College of Medicine, the College of Nursing and Health Sciences, and the University of Vermont.

More information: Health Equity Summit | The University of Vermont Health Network (uvmhealth.org)

Questions? Please email HESummit@uvmhealth.org

Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Supporting Vermont Kids: Mind Body Buddy

June 10, 2021 by Michelle Bookless

As a new pediatric resident at UVM Children’s Hospital, Nick Bonenfant, M.D.’17 (at right, with Aamani Chava, M.D.), found himself struggling with how to best support adolescents with mental health issues.
Supporting Vermont Kids: Hope for Children

June 3, 2021 by Michelle Bookless

As a new medical graduate just beginning a pediatric residency at Seattle Children’s Hospital in 2006, James Metz, M.D.’06 (at left, with Tracey Wagner, R.N., MSCN, CPN, and Mary Ellen Rafuse, MSW), never imagined that 12 years later, he’d return to his alma mater and home state as one of only two board-certified child abuse pediatricians in Vermont.
Dr. Hibba tul Rehman Awarded NNECOS Grant

June 2, 2021 by User Not Found
Dr. Shahid Ahmed Awarded NNECOS Grant

June 2, 2021 by User Not Found
Diehl & Colleagues' Latest Research Could Benefit Dengue Vaccine Development

May 28, 2021 by Jennifer Nachbur and Sean Diehl

Despite a record number of over 400 million cases in 2019, vaccine development for the mosquito-borne dengue virus has been challenging due to the need to protect equally against all four dengue strains. The discovery of new possible biomarkers to predict clinical and immune responses to dengue virus infection could be critical to informing future vaccines.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.